Radar · Life Sciences in Colorado
Best Life Sciences Companies in Colorado, United States
The 368 best Life Sciences companies in Colorado, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Somalogic.
By Riya SenguptaFinancials
368companies tracked
$5.9Bdisclosed funding
1unicorns
200have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × COLORADO
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
164companies analysed
83%cloud-native stacks
2025funding peak (by rounds)
7unicorns
2016median founding year
237kcombined LinkedIn audience
39%of audience held by top 3
6companies hiring publicly (12 mo)
Ranked: Best Life Sciences companies in Colorado
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Somalogic Developer of protein-based assays for life science research | $664M | 65 mo ago | 319 | 1999 | Larry Gold CEO | 796 patents Aptamer-based multiplexed protein/biomarker detection and quantitative proteomics assays. | — |
| 2 | Enveda 🦄 AI-based platform to decipher the chemistry of nature and develop new medicines 72Funding top 12%Moat top 32%Growth top 35%Market top 44% All 8 signals ▾Fundingtop 12% Moattop 32% Growthtop 35% Markettop 44% AItop 45% Talentbottom 49% Globalbottom 48% Techbottom 46% Funding: Raised $505M across 9 rounds · 9 rounds over 7 yrs (1.3/yr) Moat: Unicorn · 10 curated direct competitors tracked rank vs industry peers · Fliar Intelligence Index 72/100 | $505M | 9 mo ago | — | 2019 | Viswa Colluru Founder & CEO | — | — |
| 3 | Inscripta Developer of gene editing technology for research | $499M | 42 mo ago | 176 | 2015 | Andrew Garst Co-Founder | 654 patents CRISPR-based genome editing platforms and microbial metabolic engineering for isoprenoid production | — |
| 4 | Enveda Developer of an AI-enabled drug discovery platform to treat fibrosis or neurodegenerative disease | $224M | 24 mo ago | 175 | 2019 | Viswa Colluru Founder & CEO | — | 2 job openings |
| 5 | Biodesix Developer of diagnostics assays for the detection of cancer | $200M | 42 mo ago | 217 217 → 360 (+66%) | 2005 | — | 226 patents Molecular diagnostic tests for cancer, infectious diseases, and prognostic biomarkers using proteomics and AI | — |
| 6 | OnKure Therapeutics Developer of epigenetic therapies for the treatment of cancer. | $195M | 20 mo ago | 35 | 2011 | Tony Piscopio Co-founder | — | 2 job openings |
| 7 | Rezolute Developing transformative therapies for rare diseases, focusing on hyperinsulinism (HI) | $191M | 68 mo ago | 51 51 → 73 (+43%) | 2012 | Nevan Elam Co-Founder & CEO | 89 patents Therapeutic antibodies targeting insulin receptor and plasma kallikrein inhibitor drugs. | — |
| 8 | Evolutionary Genomics Developer of genes for pest and disease resistance in plants | $176M | 49 mo ago | 2 | 1990 | Steve Warnecke CEO | 75 patents Genetically engineered crops for disease resistance, drought/salt tolerance, and yield improvement | — |
| 9 | Enliven Therapeutics Developer of drugs for solid tumours and blood cancers | $140M | 26 mo ago | 27 | 2019 | Anish Patel Co-Founder | — | — |
| 10 | NeuroMark Genomics Developer of a system for chronic rhinitis treatment via radiofrequency. | $110M | 4 mo ago | — | 2018 | David Townley Co-Founder & CTO | — | — |
| 11 | Foresight Diagnostics Developer of minimally-invasive liquid biopsy test for the detection of cancer | $104M | 22 mo ago | 35 | 2020 | Ash Alizadeh Co-Founder | — | — |
| 12 | BioIntelliSense Developer of medical-grade wearable devices and data services for patient monitoring 50Funding top 21%Moat top 21%Patents top 25%Innovation top 26% All 10 signals ▾Fundingtop 21% Moattop 21% Patentstop 25% Innovationtop 26% Producttop 35% Talenttop 38% Techbottom 49% Globalbottom 40% Marketbottom 36% Customersbottom 3% Funding: Raised $82.0M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) Moat: Editorial + unicorn rating 8/10 · IP moat: 47 patents rank vs industry peers · Fliar Intelligence Index 50/100 | $82M | 6 mo ago | 26 | 2018 | James Mault Co-Founder&CEO | 47 patents Wearable multi-parameter physiological monitoring and biosensing devices | — |
| 13 | TriSalus Life Sciences Developer of drug delivery devices to treat cancers | $72M | 13 mo ago | 100 100 → 128 (+28%) | 2009 | Mary Szela CEO and President | 113 patents Patents concentrated in chemistry & materials | — |
| 14 | PharmaJet Provider of needle-free injection technology | $59M | 31 mo ago | 15 15 → 32 (+113%) | 2005 | — | 108 patents Jet injection devices for needle‑free drug delivery and precise dose control | 2 partnerships |
| 15 | VitriVax Developer of thermostable vaccines 37Funding top 23%Moat top 37%Patents top 42%Innovation top 48% All 6 signals ▾Fundingtop 23% Moattop 37% Patentstop 42% Innovationtop 48% Marketbottom 36% Globalbottom 36% Funding: Raised $55.5M across 5 rounds · 5 rounds over 6 yrs (0.8/yr) Moat: Editorial + unicorn rating 4/10 · IP moat: 7 patents rank vs industry peers · Fliar Intelligence Index 37/100 | $56M | 7 mo ago | 24 | 2014 | — | 7 patents Stable nucleic‑acid formulations and advanced chemical vapor deposition coating technologies | 1 job opening |
| 16 | Remedy Robotics Developer of endovascular robots | $35M | 8 mo ago | 12 12 → 21 (+75%) | 2020 | — | 51 patents Robotic navigation and imaging systems for endovascular catheter procedures | — |
| 17 | Viridian Therapeutics Developer of medicines for patients with serious and rare diseases | $34M | 1 mo ago | 94 | 2007 | — | — | — |
| 18 | Synergy Spine Solutions Developer of an artificial cervical disc for degenerative disc disease | $30M | 17 mo ago | 10 | 2005 | Josh Butters CEO | — | 3 launchs |
| 19 | Point Designs Provider of prosthetic fingers and partial hand prostheses 48Moat top 32%Innovation top 33%Funding top 35%Growth top 35% All 9 signals ▾Moattop 32% Innovationtop 33% Fundingtop 35% Growthtop 35% Patentstop 38% Talenttop 45% Techbottom 40% Globalbottom 31% Marketbottom 22% Moat: Editorial + unicorn rating 4/10 · IP moat: 22 patents Innovation: 22 patents (top 49% of patent-holders) · 17 filings since 2022 vs 5 in 2017-21 rank vs industry peers · Fliar Intelligence Index 48/100 | $27M | 14 mo ago | — | 2016 | Stephen Huddle Co-Founder | 22 patents Powered prosthetic hand components and actuation mechanisms for finger and thumb movement | — |
| 20 | Think Bioscience Provider of synthetic biology platform to develop small-molecule therapeutics 22Funding top 30%Talent top 38%Moat top 39%Global bottom 39% All 6 signals ▾Fundingtop 30% Talenttop 38% Moattop 39% Globalbottom 39% Techbottom 30% Marketbottom 28% Funding: Raised $26.0M across 4 rounds · 4 rounds over 6 yrs (0.7/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 22/100 | $26M | 4 mo ago | 21 21 → 31 (+48%) | 2019 | Jerome Fox Co-Founder & CEO | — | — |
| 21 | Arpeggio Provider of drug discovery platform for the treatment of cancer 24Funding top 27%Moat top 31%Talent top 38%Global bottom 37% All 6 signals ▾Fundingtop 27% Moattop 31% Talenttop 38% Globalbottom 37% Marketbottom 25% Newsbottom 22% Funding: Raised $25.4M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) Moat: Editorial + unicorn rating 8/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 24/100 | $25M | 7 mo ago | 8 | 2017 | Laura Norris Co-Founder | — | — |
| 22 | EvoEndo Developer of a medical device for un-sedated pediatric endoscopy | $21M | 22 mo ago | 17 | 2017 | Joel Friedlander Co-Founder | 22 patents Advanced flexible endoscopic systems with precise fluid, electrical, and steering control | — |
| 23 | Ambrosia Biosciences Developer of small molecule-based therapies for metabolic disorders | $16M | 2 mo ago | — | 2024 | Nick Traggis Founder & CEO | — | — |
| 24 | OncoVerity Developer of therapeutics for the treatment of cancer | $14M | 18 mo ago | — | 2022 | Max Colao CEO | — | — |
| 25 | Securisyn Developer of airway management system for ventilated patients | $11M | 10 mo ago | 10 | 2011 | Arthur Kanowitz Co-Founder & CEO | — | — |
| 26 | Exum Provider of tools and instruments for research 8Funding top 45%Tech top 45%Growth bottom 42%Global bottom 32% All 7 signals ▾Fundingtop 45% Techtop 45% Growthbottom 42% Globalbottom 32% Moatbottom 22% Marketbottom 16% Fin. healthbottom 8% Funding: Raised $9.9M across 8 rounds · 8 rounds over 7 yrs (1.1/yr) Tech: 23 technologies across 5/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 8/100 | $10M | 6 mo ago | 15 | 2017 | — | — | 1 launch |
| 27 | Armis Biopharma Developer of prophylactic therapy for MDR-surgical site infections | $9M | 11 mo ago | 10 | 2017 | — | 49 patents Patents concentrated in health & consumer products | — |
| 28 | MuscleSound Point-of-care software for malnutrition assessment and improved patient care 14Moat top 25%Innovation top 46%Patents top 48%Product top 48% All 9 signals ▾Moattop 25% Innovationtop 46% Patentstop 48% Producttop 48% Fundingtop 49% Talentbottom 49% Globalbottom 37% Techbottom 21% Marketbottom 20% Moat: Editorial + unicorn rating 6/10 · IP moat: 34 patents Innovation: 34 patents (top 39% of patent-holders) · 11 filings since 2022 vs 16 in 2017-21 rank vs industry peers · Fliar Intelligence Index 14/100 | $8M | 7 mo ago | 6 | 2011 | Stephen Kurtz Chairman & CEO | 34 patents Non‑invasive muscle metabolic and architectural assessment for fitness and medical monitoring | — |
| 29 | KromaTiD Provider of molecular and genetic tests for detection of disease-causing mutations | $7M | 11 mo ago | 31 | 2007 | — | 12 patents Cytogenetic kits and methods for chromosome stability and genotoxicity assessment | 1 internship |
| 30 | SiVEC Biotechnologies Revolutionizing therapeutics with targeted live biotherapeutic delivery platform for advanced solutions | $7M | 9 mo ago | 5 | 2016 | Lyndsey Linke Co-Founder & CEO | 37 patents Bacterial vector platforms for intracellular delivery of antibodies, proteins, and therapeutic mRNA | — |
| 31 | Liberate Medical Developing respiratory muscle stimulator technology to liberate patients from mechanical ventilation 9Funding top 38%Moat top 48%Global bottom 32%Market bottom 27% All 5 signals ▾Fundingtop 38% Moattop 48% Globalbottom 32% Marketbottom 27% Techbottom 24% Funding: Raised $6.8M across 6 rounds · 6 rounds over 10 yrs (0.6/yr) Moat: Editorial + unicorn rating 5/10 · 9 curated direct competitors tracked rank vs industry peers · Fliar Intelligence Index 9/100 | $7M | 10 mo ago | 10 | 2013 | — | — | — |
| 32 | Rock Immune Developer of immunotoxins for cancer therapy | $7M | 15 mo ago | — | 2020 | Zhirui Wang Founder | — | — |
| 33 | Crestone Pharma Manufacturer of small molecule drugs for infectious diseases | $7M | 16 mo ago | 8 | 2015 | — | — | — |
| 34 | Nice Recovery Systems Developer of a cold compression therapy device | $6M | 21 mo ago | 10 | 2012 | Michael Ross Founder | — | 1 launch |
| 35 | Photonpharma Provider of antigen presentation technology | $6M | 21 mo ago | 3 | 2019 | Amanda Guth Co-Founder & CSO | — | — |
| 36 | RheumaGen Developer of therapeutics for auto-immune diseases | $5M | 17 mo ago | 4 | 2019 | Richard Freed Co-Founder & CEO | — | — |
| 37 | Pluto Biosciences Cloud-based research data management tool for scientists | $5M | 13 mo ago | 9 | 2020 | Rani Powers Founder & CEO | — | 1 launch |
| 38 | FluoroFinder Design and search tool to find the best flow cytometry products for the panel | $5M | 12 mo ago | 12 | 2008 | John Allen CEO | — | — |
| 39 | Circa Scientific Advanced esophageal temperature monitoring systems for OR and EP lab procedures | $4M | 21 mo ago | 15 | 2009 | — | 5 patents Epicardial cardiac ablation instrument ports and transseptal crossing devices for heart procedures. | 1 job opening · 1 launch |
| 40 | HeartHero Developing next-generation AEDs to improve survival rates from cardiac arrest | $4M | 11 mo ago | 6 | 2016 | — | 35 patents Advanced AED devices integrating synchronized cardioversion, drug delivery, and adaptive power management | — |
| 41 | VitroBioPharma Biologics company developing cell therapies for autoimmune diseases and inflammatory disorders | $4M | 12 mo ago | 10 | 1986 | — | — | — |
| 42 | GelSana Developer of novel hydrogels for wound healing | $4M | 11 mo ago | 2 | 2020 | Melissa Krebs Founder & CEO | — | 1 partnership · 1 award |
| 43 | Orbit Genomics Developer of cancer diagnostics and companion diagnostics for drugs in development | $4M | 14 mo ago | 6 | 2016 | Dede Willis Co-Founder & CEO | 15 patents Microsatellite genotyping and sample classification tools for genomic analysis | — |
| 44 | Fischer Medical Technologies Innovating diagnostic imaging for early and accurate breast cancer detection | $4M | 15 mo ago | 5 | 2006 | Morgan Nields President & CEO | — | — |
| 45 | AmideBio Peptide therapeutics innovator targeting metabolic diseases with custom synthesis services | $3M | 21 mo ago | 8 | 2009 | — | 49 patents Glucose‑responsive insulin and glucagon peptide therapeutics for diabetes management | — |
| 46 | Z biotech Glycomics solutions provider advancing research with innovative glycan microarray technology | $2M | 10 mo ago | 6 | 2013 | — | 109 patents Closed-system cryopreservation devices with integrated tracking and microbial feed production technologies. | — |
| 47 | Cime Therapeutics A biotechnology company focused on advancing drug discovery through a chemistry-first platform | $2M | 14 mo ago | — | 2024 | James Brewster Co-Founder & CEO | — | — |
| 48 | Sachi Bioworks Developer of an integrative bioinformatics platform for drug discovery using AI | $2M | 14 mo ago | 5 | 2020 | Anushree Chatterjee Co-Founder & CEO | — | 1 launch |
| 49 | Neurexis Therapeutics Developer of therapeutic peptide for neuroprotective effect | $605K | 10 mo ago | 3 | 2020 | — | — | 1 launch |
| 50 | Black Dog LED Manufacturer of LED grow lights for commercial, research, and home growing. | $250K | 9 mo ago | 6 | 2010 | Corey Drew Founder & Owner | — | — |
Top 12 Life Sciences companies in Colorado
#1
Enveda 🦄Series D · Boulder, Colorado · founded 2019$504.8Mraised▾
Enveda 🦄
Series D · Boulder, Colorado · founded 2019
AI-based platform to decipher the chemistry of nature and develop new medicines. It employs advanced computational methods, high throughput automation, and metabolomics to identify potential treatments for various diseases. It leverages chemical knowledge of nature to accelerate drug discovery and development.
Fliar Intelligence Index™ 72how this company ranks against its industry peers
Funding
top 12%Moat
top 32%Growth
top 35%Market
top 44%AI
top 45%Talent
bottom 49%Funding: Raised $505M across 9 rounds · 9 rounds over 7 yrs (1.3/yr) · Last round Series D (Sep 2025)
Moat: Unicorn · 10 curated direct competitors tracked
Growth: Fresh capital in last 24 mo
Funding rounds
- Sep 2025Series D$150M
- Feb 2025Series C—
- Nov 2024Series C$130M
- Jun 2024Series B$55M
Founders & team
Investors
SVB, FPV Ventures, JAZZ Venture Partners, Level Ventures, Amino Collective, Allen & Company
Tech stack
Apple Icloud MailBootstrapCloudflareCloudflare Bot ManagementCore-JsCrazy Egg
#2
Series C · Boulder, Colorado · founded 2018$110.2Mraised▾
Series C · Boulder, Colorado · founded 2018
Developer of a system for chronic rhinitis treatment via radiofrequency. The system uses low-power energy to disrupt posterior nasal nerves. It is designed as a minimally invasive solution. The technology includes a flexible shaft and leaflets for precise treatment.
Funding rounds
- Feb 2026Series C$74.3M
- Dec 2024Series B—
- Jan 2021Series B$25M
- Jul 2020Grant (prize money)—
Founders & team
Investors
MVM, Sofinnova Partners, EQT, Atlantic Bridge, Fountain Healthcare Partners, Enterprise Ireland
Tech stack
Adobe Experience Platform LaunchCallrailCloudflareGoogle AnalyticsGoogle Tag ManagerHsts
#3
Public · Boulder, Colorado · founded 2007 · 94 employees$34.5Mraised▾
Public · Boulder, Colorado · founded 2007 · 94 employees
Developer of medicines for patients with serious and rare diseases. The company is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 29k LinkedIn followers — 12.2% of this cohort's audience
Funding rounds
- May 2026Post IPO$20M
- Feb 2015Series A$8.5M
- Sep 2010Series A$6M
Investors
Fairmount Funds Management, MRLV, Longitude Capital, Broadview Ventures
Tech stack
Apple Icloud MailCloudflareCloudflare Bot ManagementCookieyesDocusignFancybox
#4
Series C · Denver, Colorado · founded 2018 · 26 employees$82Mraised▾
Series C · Denver, Colorado · founded 2018 · 26 employees
Developer of medical-grade wearable devices and data services for patient monitoring. it provides BioButton a rechargeable, multi-parameter wearable that captures vital signssuch as heart rate, respiratory rate, and skin temperature. It is integrated with data platforms BioCloud that provides advanced analytics and algorithmic notifications to support actionable triage and workflow efficiency and BioDashboard that Enables exception-based management for more proactive clinical decision-making.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Funding
top 21%Moat
top 21%Patents
top 25%Innovation
top 26%Product
top 35%Talent
top 38%Funding: Raised $82.0M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) · Last round Series C (Dec 2025)
Moat: Editorial + unicorn rating 8/10 · IP moat: 47 patents · Soonicorn
Patents: 47 patents matched (strict assignee match) · 31 filings since 2022 vs 16 in 2017-21 · Latest publication 2026
Audience (LinkedIn): 10k LinkedIn followers — 4.1% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: CPA
Activity (LinkedIn): 1 partnerships (incl. Hillcrest HealthCare System) announced in 12 mo
Funding rounds
- Dec 2025Series C$58.1M
- Jul 2021Series B$45M
- Aug 2020Series B$12M
- Dec 2018Series B$25M
Founders & team
Investors
Chimera, 7wire Ventures, Pendrell, Fresenius Medical Care, Triple Tree, UCHealth
#5
Series B · Boulder, Colorado · founded 2024$16Mraised▾
Series B · Boulder, Colorado · founded 2024
Developer of small molecule-based therapies for metabolic disorders. It offers an enzyme technology platform that converts obesity-promoting sugars into minimal-calorie rare sugars to treat obesity.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers
Funding rounds
- Mar 2026Series B$100M
- Jul 2024Series A$16M
Founders & team
Investors
BVF Partners, Boulder Ventures, Blue Owl Healthcare Opportunities, Redmile Group, Deep Track Capital, Janus Henderson Investors
Tech stack
Animate.CssAosBootstrapCloudflareCloudflare Bot ManagementCore-Js
#6
Series A · Boulder, Colorado · founded 2019 · 21 employees$26Mraised▾
Series A · Boulder, Colorado · founded 2019 · 21 employees
Provider of synthetic biology platform to develop small-molecule therapeutics. The company's platform combines applied microbiology, enzymology, and data science to develop medicines against difficult-to-drug proteins.
Fliar Intelligence Index™ 22how this company ranks against its industry peers
Funding
top 30%Talent
top 38%Moat
top 39%Global
bottom 39%Tech
bottom 30%Market
bottom 28%Funding: Raised $26.0M across 4 rounds · 4 rounds over 6 yrs (0.7/yr) · Last round Series A (Jan 2026)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 7/10 · 10 curated direct competitors tracked
Audience (LinkedIn): 4k LinkedIn followers
Funding rounds
- Jan 2026Series A$55M
- May 2024Seed$6M
- Aug 2022Seed$17M
- Dec 2020Grant (prize money)$255.9K
Founders & team
Investors
America’s Seed Fund, Innovation Endeavors, Xora Innovation, AV8 Ventures, Buff Gold Ventures, LiquidMetal Ventures
#7
Series B · Boulder, Colorado · founded 2014 · 24 employees$55.5Mraised▾
Series B · Boulder, Colorado · founded 2014 · 24 employees
Developer of thermostable vaccines and vaccine formulations. It is using a proprietary platform technology named a single shot, prime + boost microparticle vaccine platform and developed at the University of Colorado. The platform uses nanoparticles of antigen and adjuvant in an amorphous disaccharide glass matrix, which improves the stability and solubility of the product. The company is using the platform to develop thermostable vaccines of Anthrax, Botulinum toxin, Ebola glycoprotein, and HPV16 L1 capsomere.
Fliar Intelligence Index™ 37how this company ranks against its industry peers
Funding
top 23%Moat
top 37%Patents
top 42%Innovation
top 48%Market
bottom 36%Global
bottom 36%Funding: Raised $55.5M across 5 rounds · 5 rounds over 6 yrs (0.8/yr) · Last round Series B (Oct 2025)
Moat: Editorial + unicorn rating 4/10 · IP moat: 7 patents · Soonicorn
Patents: 7 patents matched (strict assignee match) · 7 filings since 2022 vs 0 in 2017-21 · Latest publication 2026
Audience (LinkedIn): 2k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Senior Scientist, Principal Scientist – Pharmacology and Toxicology
Activity (LinkedIn): 1 partnerships (incl. BioMed Realty) announced in 12 mo
Funding rounds
- Oct 2025Series B$17.2M
- Jun 2025Series B$29.4M
- Apr 2025Grant (prize money)$5M
- Dec 2024Grant (prize money)$3.6M
Investors
Gates, Adjuvant Capital, CEPI, RA Capital Management
#8
Series B · Boulder, Colorado · founded 2017 · 8 employees$25.4Mraised▾
Series B · Boulder, Colorado · founded 2017 · 8 employees
Provider of drug discovery platform for the treatment of cancer. The company uses DNA sequencing and CRISPR-based screening technology to identify therapeutic targets and biomarkers to treat cancer. The company is developing drug candidates for Sarcomas, Lung Adenocarcinoma, and autoimmune diseases.
Fliar Intelligence Index™ 24how this company ranks against its industry peers
Funding
top 27%Moat
top 31%Talent
top 38%Global
bottom 37%Market
bottom 25%News
bottom 22%Funding: Raised $25.4M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) · Last round Series B (Nov 2025)
Moat: Editorial + unicorn rating 8/10 · Soonicorn · 10 curated direct competitors tracked
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Audience (LinkedIn): 3k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: translational biologists
Funding rounds
- Nov 2025Series B$20M
- Mar 2025Series A$4M
- Aug 2022Series A$20.2M
- Jan 2020Seed$3.2M
Founders & team
Investors
Builders VC, Khosla Ventures, TechU, Fifty Years, Formic Ventures, Tau Ventures
#9
Series A · Denver, Colorado · founded 2020 · 12 employees$35Mraised▾
Series A · Denver, Colorado · founded 2020 · 12 employees
Developer of endovascular robots. It offers solutions for doctors to conduct vascular interventions like placing stents in patients. The robots can be remotely operated.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Funding rounds
- Oct 2025Series A$35M
Investors
Axios, Blackbird Ventures, DCVC, KdT Ventures, Pathbreaker Ventures, Divergent Capital
Tech stack
Apple Icloud MailCloudflareGoogle AnalyticsGoogle WorkspaceGsapHsts
#10
Series A · Denver, Colorado · founded 2017 · 15 employees$9.9Mraised▾
Series A · Denver, Colorado · founded 2017 · 15 employees
Provider of tools and instruments for research. The lead instrument, The Massbox, is the first Laser Ablation Laser Ionization Time of Flight Mass Spectrometer (LALI-TOF-MS) instrument on the market, capable of analyzing any sample, increasing the speed of development and discovery.
Fliar Intelligence Index™ 8how this company ranks against its industry peers
Funding
top 45%Tech
top 45%Growth
bottom 42%Global
bottom 32%Moat
bottom 22%Market
bottom 16%Funding: Raised $9.9M across 8 rounds · 8 rounds over 7 yrs (1.1/yr) · Last round Series A (Dec 2025)
Tech: 23 technologies across 5/8 capability areas · Cloud: Cloudflare · Observability: Microsoft Clarity
Growth: Revenue -73% YoY · Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Audience (LinkedIn): 4k LinkedIn followers
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Dec 2025Series A$120K
- Apr 2025Series A$1.1M
- Jul 2024Series A$1.5M
- May 2023Series A$6M
Investors
MassChallenge, EIC Rose Rock, Advantage Capital, 46VC, Boyd Street Ventures, Alchemy Capital Management
Tech stack
CdnjsCloudflareCloudflare Bot ManagementCore-JsGoogle AnalyticsGoogle Font Api
#11
Public · Westminster, Colorado · founded 2009 · 100 employees$72.3Mraised▾
Public · Westminster, Colorado · founded 2009 · 100 employees
TriSalus Life Sciences is involved in developing drug delivery devices to treat cancers. They have developed a technology platform, Pressure-Enabled Drug Delivery (PEDD), which is designed to improve the distribution and penetration of therapy in solid tumors.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 2.7% of this cohort's audience
Funding rounds
- Apr 2025Post IPO$22M
- Dec 2024Post IPO$1000K
- Oct 2022Post IPO$15.3M
- Sep 2021Post IPO$23.5M
Founders & team
Investors
MCG Capital, Partisan Management Group, High Country Ventures, Tullis Health Investors, KMG Capital Partners, Mcg Partners
Tech stack
Acquia Cloud PlatformAcquia Cloud Site FactoryAdobe AnalyticsAdobe Experience Platform Identity ServiceAdobe Experience Platform LaunchAmazon Web Services
#12
Public · Longmont, Colorado · founded 2011 · 35 employees$195.2Mraised▾
Public · Longmont, Colorado · founded 2011 · 35 employees
Developer of epigenetic therapies for the treatment of cancer. It's lead drug ONK179, an HDAC 6 inhibitor which is being developed for the treatment of hematological and solid tumor cancers and ONK102 has reduced the growth rate of tumours when dosed by itself or in combination with other targeted therapies.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers
Hiring: 2 hiring posts in 12 mo (public) · momentum +2 · hiring: Director/Senior Director, Analytical Chemistry
Funding rounds
- Oct 2024Series C$65M
- Mar 2023Series C$54M
- Mar 2021Series B$56.6M
- Sep 2020Series A$1.5M
Founders & team
Investors
Acorn Bioventures, Samsara BioCapital, Perceptive Advisors, BlackRock, Surveyor Capital, Deep Track Capital
Tech stack
AccessibeCookieyesDocusignGodaddyGoogle AnalyticsHttp/3
Funding & investor landscape
$5.9Btotal disclosed funding
207companies funded
813disclosed rounds
2rounds last 90 days
Most active investors
Notable founders
Viswa Colluru
Founder & CEO · Enveda
David Townley
Co-Founder & CTO · NeuroMark Genomics
Brian Shields
Co-Founder & CEO · NeuroMark Genomics
David Wang
CEO · BioIntelliSense
James Mault
Co-Founder&CEO · BioIntelliSense
Nick Traggis
Founder & CEO · Ambrosia Biosciences
Jerome Fox
Co-Founder & CEO · Think Bioscience
Philip Jeng
Co-Founder & COO & CFO · Think Bioscience
Laura Norris
Co-Founder · Arpeggio
Joey Azofeifa
Co-Founder · Arpeggio
Mary Szela
CEO and President · TriSalus Life Sciences
Tony Piscopio
Co-founder · OnKure Therapeutics
Prism market signals · United States · country-scoped Prism corpus, 1,465,538 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN COLORADO · Health & Bio
How research on Biotechnology in Colorado is moving
A read on the academic research around Biotechnology in Colorado — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 90 papers.
Colorado State University leads Colorado's biotechnology research (90 papers, stance +0.50).
90 papers · stance +0.50 · 43% breakthrough · 16% concern
top institutions
- Colorado State University32
- University of Colorado Anschutz Medical Campus29
- University of Colorado Denver17
- University of Colorado Boulder17
- Children\'s Hospital Colorado7
leading researchers
Lingbo Li · Francis J. Fields · H. Liu · Hughes, Ellen · Li, Yin · Mashiro Shirasawa
prism intelligence · tone & topics
89% positive · 7% critical tone
Medical ResearchHealthPharmaceuticalsBiologyAgricultureGenetics
▲
Breakthroughs34 · 38%
▲ 24%→42% share
▲1.8× share momentum0 median citations88% since 2021mostly empirical
Breakthroughs are rising (24%→42% of field), led by Gene.
rising sub-themes (early→recent)
- Gene6
- RNA polymerase II5
- Messenger RNA4
- Polymerase4
- Transcription (linguistics)4
Newly emergingGene 0→6 · RNA polymerase II 0→5 · Messenger RNA 0→4
Landmark Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery · 1,692 cites
◆
Advancements32 · 36%
▼ 47%→32% share
▼0.7× share momentum0 median citations72% since 2021mostly empirical
Advancements are cooling (47%→32% of field), led by Transcriptome.
rising sub-themes (early→recent)
- Transcriptome1→3
Newly emergingGene expression 0→3 · Downregulation and upregulation 0→3
Landmark Hydrogels as extracellular matrix mimics for 3D cell culture · 2,655 cites
▼
Concerns13 · 14%
▼ 29%→10% share
▼0.3× share momentum0 median citations54% since 2021mostly empirical
Concerns are cooling (29%→10% of field), led by Gene.
rising sub-themes (early→recent)
- Gene2
- Gut flora2
- Self-healing hydrogels1
- In vivo1
- Biophysics1
Landmark Deconstruction of Lignocellulosic Biomass to Fuels and Chemicals · 1,017 cites
Common questions
How many Life Sciences companies are there in Colorado, United States?
Radar tracks 368 indexable Life Sciences companies headquartered in Colorado, United States that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Colorado, United States?
The Life Sciences companies in Colorado, United States on this list have raised a combined $5.9B in disclosed equity funding across 207 funded companies.
Which is the highest-funded Life Sciences company in Colorado, United States?
Somalogic is the highest-funded Life Sciences company in Colorado, United States, with $664M in disclosed equity funding.
How many Life Sciences companies in Colorado, United States are funded?
207 of the 368 Life Sciences companies in Colorado, United States on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Colorado, United States?
1 Life Sciences company in Colorado, United States on this list is valued at $1B or more.
Who are the top investors in Colorado, United States Life Sciences companies?
The most active investors in Colorado, United States Life Sciences companies on this list include HHS, Innosphere, Colorado Office of Economic Development and International Trade, National Science Foundation, NIH.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.